Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo 英文论文文献.docVIP

BMC Cancer BioMedCentral Research article Open Access Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo Frank M Klenke1, Amir Abdollahi2, Elisabeth Bertl3, Martha-Maria Gebhard4, Volker Ewerbeck5, Peter E Huber2 and Axel Sckell*6 Address: 1Department of Orthopedic Surgery, Inselspital, University of Bern, CH-3010 Bern, Switzerland, 2Department of Radiation Oncology, German Cancer Research Center, INF 280, D69120 Heidelberg, Germany, 3Division of Toxicology and Cancer Risk Factors, German Cancer Research Center, INF 280, D-69120 Heidelberg, Germ